Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 3
2006 4
2007 2
2008 3
2009 5
2010 1
2011 1
2012 1
2013 4
2014 4
2015 2
2016 4
2017 2
2022 7
2023 5
2024 9
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management.
Fatica M, D'Antonio A, Novelli L, Triggianese P, Conigliaro P, Greco E, Bergamini A, Perricone C, Chimenti MS. Fatica M, et al. Among authors: bergamini a. Curr Rheumatol Rep. 2023 Jan;25(1):12-33. doi: 10.1007/s11926-022-01092-4. Epub 2022 Oct 29. Curr Rheumatol Rep. 2023. PMID: 36308677 Free PMC article. Review.
The steroid-sparing effect of JAK inhibitors across multiple patient populations.
Conigliaro P, Minerba C, Vendola A, Fiannacca L, Triggianese P, Kroegler B, Greco E, Bergamini A, Chimenti MS. Conigliaro P, et al. Among authors: bergamini a. Front Immunol. 2024 Apr 12;15:1376476. doi: 10.3389/fimmu.2024.1376476. eCollection 2024. Front Immunol. 2024. PMID: 38680499 Free PMC article.
Study of lncRNAs expression profile in the response to biological drugs in Psoriatic Arthritis: MEG3 could be a potential genomic biomarker of therapy efficacy.
De Benedittis G, D'Antonio A, Latini A, Morgante C, Conigliaro P, Triggianese P, Bergamini A, Novelli G, Ciccacci C, Chimenti MS, Borgiani P. De Benedittis G, et al. Among authors: bergamini a. Int Immunopharmacol. 2024 Jun 15;134:112239. doi: 10.1016/j.intimp.2024.112239. Epub 2024 May 17. Int Immunopharmacol. 2024. PMID: 38761785 Free article.
Risankizumab Efficacy in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Remission: A Case Report on Rheumatologic and Dermatologic Disease Manifestations with Literature Review.
Ferraioli M, Fiannacca L, Greco E, Cela E, Fatica M, Bergamini A, Chimenti MS. Ferraioli M, et al. Among authors: bergamini a. Case Reports Immunol. 2024 Mar 19;2024:9076852. doi: 10.1155/2024/9076852. eCollection 2024. Case Reports Immunol. 2024. PMID: 38533274 Free PMC article.
52 results